PNPLA3 and liver disorder: Second, our study highlights how menopausal women (≥55 years), so far neglected in clinical studies of liver disease, when carrying the PNPLA3 p.I148M variant may become a clinically distinct and relevant subset to target with a precision therapy approach15.